Extended use of point-of-care technology versus usual care for in-home assessment by acute community nurses in older adults with signs of potential acute respiratory disease: an open-label randomised controlled trial protocol
- PMID: 38365595
- PMCID: PMC10870485
- DOI: 10.1186/s12877-024-04774-z
Extended use of point-of-care technology versus usual care for in-home assessment by acute community nurses in older adults with signs of potential acute respiratory disease: an open-label randomised controlled trial protocol
Abstract
Background: Due to ageing-related physiological changes, diagnosing older adults is challenging. Delayed disease recognition may lead to adverse health outcomes and increased hospitalisation, necessitating the development of new initiatives for timely diagnosis and treatment of older adults. Point-of-care technology, such as focused lung ultrasound scan and bedside analysis of blood samples (leucocytes with differential count, electrolytes, and creatinine) conducted in the patients' home, may support clinical decision-making, and potentially reduce acute hospital admissions. We present the protocol for a randomized controlled trial, which aims at assessing the effect of focused lung ultrasound scan and bedside blood analysis during in-home assessments among older adults with signs of potential acute respiratory disease on hospital admissions.
Method: We will use a parallel open-label, individually randomised controlled trial design in an acute community healthcare setting. The trial will initiate on October 2022 and is expected to end one year later. The study population will include older adults (65 + year), with at least one of the following inclusion criteria: Cough, dyspnoea, fever, fall, or rapid functional decline. Expected study sample will comprise 632 participants. Participants in the control group will receive usual care, while the intervention group will undergo extended point-of-care technology (focused lung ultrasound scan and bedside venous blood analysis), in addition to usual care. The primary outcome is acute hospital admission within 30 days follow-up. Secondary outcomes include readmissions, mortality, length of hospital stay, hospital-free days, complications during hospital admission, treatment initiations or changes, functional level, re-referrals to the acute community healthcare service, and contacts to the primary care physician. A tertiary outcome is the diagnostic accuracy of Acute Community Nurses for conducting focused lung ultrasound compared with a specialist. Outcomes will be analysed as intention-to-treat.
Discussion: To our knowledge, this is the first randomised controlled trial examining the effect of extended use of point-of-care technology conducted in an in-home setting. We expect that the results may contribute to the development of new interventions aiming to improve timely diagnostics, treatment decisions, and reduce acute hospital admissions.
Trial registration: www.
Clinicaltrials: org NCT05546073 (Date of registration: September 19th, 2022).
Keywords: Acute community nurse; Focused lung ultrasound; Geriatric Assessment; Point-of-care technology.
© 2024. The Author(s).
Conflict of interest statement
SAS declare no competing interest.
CBL has in the past 36 months received speaker’s honoraria for lectures at educational events / symposia / courses organised by AstraZeneca, and royalties as author of book chapters or as editor of books / web publications by Munksgaard.
DEJ declare no competing interest.
FSR declare no competing interest.
KAR declare no competing interest.
Figures
Similar articles
-
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0. Trials. 2021. PMID: 33810796 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Improving diagnostics using extended point-of-care testing during in-home assessments of older adults with signs of emerging acute disease: a prospective observational non-randomised pilot and feasibility study.BMC Geriatr. 2024 Apr 25;24(1):373. doi: 10.1186/s12877-024-04914-5. BMC Geriatr. 2024. PMID: 38664633 Free PMC article.
-
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1. Trials. 2021. PMID: 33407777 Free PMC article.
-
A randomised controlled trial to prevent hospital readmissions and loss of functional ability in high risk older adults: a study protocol.BMC Health Serv Res. 2011 Aug 23;11:202. doi: 10.1186/1472-6963-11-202. BMC Health Serv Res. 2011. PMID: 21861920 Free PMC article. Clinical Trial.
Cited by
-
Evaluating general practitioners' focused lung ultrasound competence and findings in patients with suspected community-acquired pneumonia in general practice.Scand J Prim Health Care. 2025 Jun;43(2):359-369. doi: 10.1080/02813432.2024.2447083. Epub 2024 Dec 30. Scand J Prim Health Care. 2025. PMID: 39736112 Free PMC article.
References
-
- Eurostat. People in the EU: Who are we and how do we live. Luxembourg: Publications Office of the European Union: European Union; 2015. 10.2785/406462.
-
- Keeble E, Roberts HC, Williams CD, Van Oppen J, Conroy SP. Outcomes of hospital admissions among frail older people: a 2-year cohort study. The British journal of general practice : the journal of the Royal College of General Practitioners. 2019;69:e555–e560. doi: 10.3399/bjgp19X704621. - DOI - PMC - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical